EQHQ
Login
EQHQ
Search your stocks
Login
Command Palette
Search for a command to run...
Explore
Watchlists
Chat
Portfolio
Share
Profile
Concord Drugs Ltd.
Overview
Shareholding
Peers
Financials
Ratios
Concall
Feed
Documents
Concord Drugs Ltd.
Concord Drugs Ltd.
68
(+1.22%)
1W: +1.79%
1M: +17.86%
1Y: +87.13%
Ratios
Cash Conversion Cycle
Latest:
260.5 days
Return on Equity
Latest:
1.5%
Return on Capital Employed
Latest:
5.0%
Dupont Analysis
Analysis Summary
Metric
Mar 2022
Mar 2023
Mar 2024
ROE
5.62%
3.31%
1.45%
PAT margin
1.05%
1.89%
2.70%
Asset Turnover
1.04x
0.91x
0.77x
Leverage
1.99x
1.93x
1.80x
Efficiency Ratios
Analysis Summary
Metric
Mar 2022
Mar 2023
Mar 2024
Inventory Days
108.3
131.6
174.6
Receivable Days
141.5
135.5
144.8
Payable Days
96.9
78.0
58.9
Cash Conversion Cycle
152.9
189.1
260.5
Return Ratios
Analysis Summary
Metric
Mar 2022
Mar 2023
Mar 2024
ROE
5.62%
3.31%
1.45%
ROCE
8.77%
6.32%
4.99%
ROA
2.82%
1.72%
0.81%
Explore
Watchlists
Chat
Portfolio